戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              CFTR activators have potential therapeutic indications i
2                                              CFTR channel gating is strictly coupled to phosphorylati
3                                              CFTR dysfunction affects innate immune pathways, generat
4                                              CFTR dysfunction mainly affects epithelial cells, althou
5                                              CFTR is a major prosecretory chloride channel at the ocu
6                                              CFTR is expressed in various cell types, including leuko
7                                              CFTR modulator therapy with tezacaftor-ivacaftor or ivac
8                                              CFTR sequencing demonstrated that she is a carrier for a
9                                              CFTR, the chloride channel mutated in cystic fibrosis (C
10                                              CFTR, the cystic fibrosis (CF) gene, encodes for the CFT
11 definition of the druggability of the 14-3-3-CFTR interface might offer an approach for cystic fibros
12 confirmed diagnosis of cystic fibrosis and a CFTR gating mutation on at least one allele from 15 hosp
13 eterozygous for the Phe508del mutation and a CFTR mutation associated with residual CFTR function.
14 eterozygous for the Phe508del deletion and a CFTR residual-function mutation.
15                              However, both a CFTR corrector and potentiator enhanced activity of prot
16 ith a recently solved cryo-EM structure of a CFTR IWF state.
17 r alone or in combination with tezacaftor, a CFTR corrector, in 248 patients 12 years of age or older
18 -) currents, but unexpectedly also abrogates CFTR-mediated Cl(-) secretion and completely abolishes c
19 he most potent compound, 12, fully activated CFTR chloride conductance with EC50 approximately 30 nM,
20 3,5-triazine CFTRact-K089 (1) that activated CFTR with EC50 approximately 250 nM, which when delivere
21       These data indicate that H2S activates CFTR in Xenopus oocytes by inhibiting phosphodiesterase
22 ata provide insights into how loss of active CFTR at the membrane can have additional consequences be
23 ane Conductance Regulator (CFTR) gene affect CFTR protein biogenesis or its function as a chloride ch
24 t the C-terminal PDZ-domain of both A2BR and CFTR were crucial for this interaction, and that replaci
25  independent screens, firefly luciferase and CFTR-mediated transepithelial chloride conductance assay
26 xtensively investigated, phosphorylation and CFTR-ATPase activity are still poorly understood.
27 by cAMP-dependent protein kinase A (PKA) and CFTR-ATPase activity.
28 gnificant ABCC transporters (MRP1, SUR1, and CFTR), determined by using single-particle cryo-electron
29 or (VX-770; Kalydeco), a clinically approved CFTR potentiator.
30 e proteostasis of other membrane proteins as CFTR and anthrax toxin receptor 2, two poor folders invo
31                         To understand better CFTR function, we investigated the regulation of channel
32 o better understand the relationship between CFTR activity, airway microbiology and inflammation, and
33                     (R)-BPO-27 fully blocked CFTR chloride conductance in epithelial cell cultures an
34 l information on the unique ABC ion channel, CFTR, hinders elucidation of its functional mechanism an
35                               After complete CFTR sequencing, the method found three cryptic intronic
36 ulator (CFTR) gene, is capable of correcting CFTR-dependent chloride transport in cystic fibrosis hum
37 otal enhancer element dramatically decreases CFTR expression, but has minor effect on its 3D structur
38 ack of an effect of C4 on I507-ATC DeltaF508 CFTR, but its additive effect in combination with VX-809
39  acted on VX-809-modified I507-ATC DeltaF508 CFTR.
40             C4 stabilized I507-ATT DeltaF508 CFTR band B, but without considerable biochemical and fu
41 ugs are being developed to correct DeltaF508 CFTR.
42 ansmembrane conductance regulator (DeltaF508 CFTR), the most frequent disease-associated mutant of CF
43 281, whereas others also corrected DeltaF508-CFTR.
44 /potentiator strategy, as used for DeltaF508-CFTR, to produce functional rescue of the truncated tran
45  the loss-of-function phenotype of DeltaF508-CFTR suggest that the ribosomal stalk modulates the fold
46  VAPB inhibited the degradation of DeltaF508-CFTR.
47 romyces cerevisiae phenocopies the DeltaF508-CFTR folding and trafficking defects.
48 eutic target for correction of the DeltaF508-CFTR folding defect.
49 these candidate genes enhanced the DeltaF508-CFTR functional expression at the apical PM in human CF
50 Pase and gating activity of dephosphorylated CFTR.
51          Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of d
52 itive model for VAP interactions that direct CFTR biogenesis.
53 mparison with MRP1, a feature distinguishing CFTR from all other ABC transporters is the helix-loop t
54  that cigarette smoke not only downregulates CFTR activity but also inhibits BK channel function, the
55 context of its three upstream and downstream CFTR codons during G418-mediated suppression.
56                The presence of dysfunctional CFTRs in enteric ganglia could, to a certain extent, exp
57 nels into a closed state and that endogenous CFTR in HBEs is affected by SMase activity.
58                                Na2S enhanced CFTR stimulation by membrane-permeable 8Br-cAMP under in
59 orrector-potentiator therapy, which enhances CFTR transport to the membrane, have increased PTEN amou
60 -channel recording, whereas to assess entire CFTR populations, we used purified CFTR proteins and mac
61 ht produce a greater benefit than expressing CFTR at wild-type levels when targeting small fractions
62 nsitive mutant cystic fibrosis channel (F508-CFTR) at the plasma membrane and after reconstitution in
63  concomitant functional inactivation of F508-CFTR are partially suppressed by constitutive activity o
64 contribute to functional maintenance of F508-CFTR by reshaping the conformational energetics of its f
65  SUMOylation, to selectively degrade F508del CFTR via the SUMO-targeted ubiquitin E3 ligase, RNF4 (RI
66 ic fibrosis patients with the common F508del-CFTR mutation.
67 PARP-16 and their ability to correct F508del-CFTR trafficking.
68  with cystic fibrosis homozygous for F508del-CFTR in an open-label study.
69 h cystic fibrosis and homozygous for F508del-CFTR, but it has not been assessed in younger patients.
70 tic fibrosis who were homozygous for F508del-CFTR.
71  with cystic fibrosis homozygous for F508del-CFTR.
72 rosis aged 6-11 years homozygous for F508del-CFTR.
73 ated autophagy in primary homozygous F508del-CFTR human bronchial epithelial (hBE) cells at submicrom
74  targets to correct basic defects in F508del-CFTR processing.
75 onic co-incubation greatly increased F508del-CFTR channel activity and temporal stability in most, bu
76 y delayed deactivation of individual F508del-CFTR Cl(-) channels.
77 tor further destabilized full-length F508del-CFTR and accelerated channel deactivation.
78 ally stabilized purified full-length F508del-CFTR and slightly delayed deactivation of individual F50
79 fied wild-type CFTR, the full-length F508del-CFTR was about 10 degrees C less thermostable.
80 nd ivacaftor deactivated macroscopic F508del-CFTR Cl(-) currents.
81 tability in a small subpopulation of F508del-CFTR Cl(-) channels but that the majority remain destabi
82 a membrane targeting and function of F508del-CFTR, but not of wild-type CFTR.
83 hese compounds on the instability of F508del-CFTR, the most common CF mutation.
84 Chronic (prolonged) co-incubation of F508del-CFTR-expressing cells with lumacaftor and ivacaftor deac
85 hose silencing significantly rescued F508del-CFTR activity, as indicated by enhanced anion transport
86 7 degrees C, low temperature-rescued F508del-CFTR more rapidly lost function in cell-free membrane pa
87 f proteins whose suppression rescues F508del-CFTR function in bronchial epithelial cells.
88 nd the characterization of the small F508del-CFTR subpopulation might be crucial for CF therapy devel
89 ultaneously act as correctors of the F508del-CFTR folding defect and as broad-spectrum antivirals aga
90 g; eligible patients had to have the F508del-CFTR mutation on both alleles.
91 ears or older and homozygous for the F508del-CFTR mutation.
92 stic fibrosis and homozygous for the F508del-CFTR mutation.
93 To identify proteins associated with F508del-CFTR processing, we used a high-throughput functional as
94  CFTR and that this modification facilitates CFTR channel activation.
95  which likely forms the structural basis for CFTR's channel function.
96 side in NBD2, and the domain is critical for CFTR function, because channel gating involves NBD1/NBD2
97      Our studies reveal a novel function for CFTR in antiviral immunity and demonstrate that the Delt
98 ARP-3 and -16 and that this is necessary for CFTR correction.
99 cidated structure-activity relationships for CFTR activation and identified substantially more potent
100                 All patients were tested for CFTR genotype at screening; eligible patients had to hav
101 ummary, we have described a direct link from CFTR to Ezrin to PI3K/AKT signaling that is disrupted in
102 rously validated candidates using functional CFTR maturation and electrolyte transport assays in pola
103 ion in people with cystic fibrosis and G551D-CFTR mutations but does not reduce density of bacteria o
104            We studied 12 subjects with G551D-CFTR mutations and chronic airway infections before and
105 ographic lung disease in subjects with G551D-CFTR mutations.
106 CF transmembrane conductance regulator gene (CFTR).
107 ocyte expression system to shed light on how CFTR channel activity is reduced by SMase.
108                                        Human CFTR was heterologously expressed in Xenopus oocytes and
109  identical structures of zebrafish and human CFTR in the dephosphorylated, ATP-free form.
110  a 3.9 A structure of dephosphorylated human CFTR without nucleotides, determined by electron cryomic
111 tigated the single-channel activity of human CFTR at different intracellular pH (pHi ) values.
112 st nucleotide-binding domain (NBD1) of human CFTR.
113                                    The human CFTR structure reveals a previously unresolved helix bel
114              Close resemblance of this human CFTR structure to zebrafish CFTR under identical conditi
115                                        (iii) CFTR-ATPase activity is inversely related to CFTR anion
116          Synthesized analogs showed improved CFTR activation potency compared to 4 with EC50 down to
117         These findings suggest that improved CFTR trafficking could enhance P. aeruginosa clearance f
118 Riquelme et al. (2017) propose that improved CFTR trafficking could enhance P. aeruginosa clearance t
119 ith two ATP-binding sites, sites 1 and 2, in CFTR.
120 (-) transport given that neither a change in CFTR-dependent HCO3 (-) efflux nor Na(+) /HCO3 (-) cotra
121 turbing the gating conformational changes in CFTR's transmembrane domains (TMDs) without altering the
122 utations may impose combinatorial defects in CFTR channel biology.
123 ned action for 8 h and was without effect in CFTR-deficient mice.
124                      Both mechanisms fail in CFTR(-/-) swine, suggesting that cystic fibrosis airways
125 osine- and forskolin-stimulated increases in CFTR-dependent transepithelial short-circuit current, in
126 ains the catalytically active ATPase site in CFTR.
127 f 21 (86%) known splice-altering variants in CFTR, a well-studied gene whose loss-of-function variant
128  absorption, while anion channels, including CFTR and Ca(2+)-activated chloride channels mediate anio
129 the apical side of cholangiocytes, including CFTR and SLC5A1, as well as reduced expression of IGF1.
130                   In epithelia, an increased CFTR activity may correspond to a pro-secretory response
131 ology: it reduced inflammation and increased CFTR maturation, stability and activity.
132 nd report protein kinase A (PKA)-independent CFTR activation by calmodulin.
133                          To study individual CFTR Cl(-) channels, we performed single-channel recordi
134 is not membrane delimited and that inhibited CFTR channels remain at the cell membrane, indicative of
135 ido-pyrrolo-oxazinedione (R)-BPO-27 inhibits CFTR chloride conductance with low-nanomolar potency.
136 sm by which sphingomyelin catalysis inhibits CFTR is not known but evidence suggests that it occurs i
137 ther, these data suggest that SMase inhibits CFTR channel function by locking channels into a closed
138          Sphingomyelinase C (SMase) inhibits CFTR chloride channel activity in multiple cell systems,
139                   In humans and pigs lacking CFTR, unchecked H(+) secretion by the nongastric H(+)/K(
140        Here, we studied purified full-length CFTR protein using spectroscopic techniques to determine
141               Here, we show that Ezrin links CFTR and TLR4 signaling, and is necessary for PI3K/AKT s
142  used purified CFTR proteins and macroscopic CFTR Cl(-) currents.
143 e have previously shown that plasma membrane CFTR increases the surface density of the adenosine 2B r
144 el, results in the production of a misfolded CFTR protein, which has residual channel activity but is
145                               Small-molecule CFTR activators increase tear secretion and prevent expe
146                         Airway smooth muscle CFTR may represent a therapeutic target in CF and other
147 ing response to therapies directed at mutant CFTR.
148 oes not restore activity to Phe508del mutant CFTR.
149                                  Some mutant CFTR proteins show residual function and respond to the
150 tial physical interaction of FAU with mutant CFTR, leading to its degradation.
151 itical for the regulated channel activity of CFTR.
152 centration provides an in vivo assessment of CFTR function, but it is unknown the degree to which CFT
153    To understand better the kinetic basis of CFTR intraburst gating, we investigated the single-chann
154                      The gating behaviour of CFTR is characterized by bursts of channel openings inte
155  be required to realize the full benefits of CFTR-targeting treatments.
156 e bicarbonate permeability (P HC O3/ Cl ) of CFTR, ANO1 and GlyR.
157                 Furthermore, coexpression of CFTR stimulated SLC26A6-mediated Cl(-)-oxalate exchange
158 ed on the molecular phenotypic complexity of CFTR mutants and their susceptibility to pharmacotherapy
159 s in length and weight with no correction of CFTR function.
160      By analyzing the sigmoid time course of CFTR current activation, we propose that PKA phosphoryla
161  GYY4137 increased transmembrane currents of CFTR-expressing oocytes.
162  Phosphorylation of the regulatory domain of CFTR by protein kinase A (PKA) is required for its chann
163 ce between the catalytic and pore domains of CFTR and that this modification facilitates CFTR channel
164 tion of channel openings, the dysfunction of CFTR in CF and the action of drugs that repair CFTR gati
165                                  Evidence of CFTR binding to isolated calmodulin domains/lobes sugges
166                  The extensive expression of CFTR in the enteric ganglia suggests that CFTR may play
167                                Expression of CFTR protein and mRNA was detected in neurons of the gan
168 proper activation and membrane expression of CFTR.
169 ed secretory chloride channel independent of CFTR.
170 d inflammation may progress independently of CFTR activity once cystic fibrosis lung disease is estab
171 nce suggests that it occurs independently of CFTR's regulatory "R" domain.
172   Importantly, pharmacological inhibition of CFTR abrogated enteroid fluid secretion, providing proof
173 suppression to restore therapeutic levels of CFTR function.
174 ng insights into the molecular mechanisms of CFTR function.
175 e most frequent disease-associated mutant of CFTR, may affect protein biogenesis, structure, and func
176 p is the cause for the functional overlap of CFTR and Ca(2+)-dependent chloride transport.
177 ine-induced cAMP response in the presence of CFTR.
178 ing the HCO3(-) /Cl(-) permeability ratio of CFTR from 0.4 to 1.0 had little impact upon either the s
179 interaction between the regulatory region of CFTR and calmodulin, the major calcium signaling molecul
180 his study, we investigated the regulation of CFTR by H2S.
181 her, our data suggest that the regulation of CFTR intraburst gating is distinct from the ATP-dependen
182                      Furthermore, removal of CFTR's PDZ binding motif (DeltaTRL) prevented actin rear
183  here, we investigate the direct response of CFTR to calmodulin-mediated calcium signaling.
184 s/lobes suggests a mechanism for the role of CFTR as a molecular hub.
185 ta highlight the critical regulatory role of CFTR in integrin activation by chemoattractants in monoc
186 erase activity and subsequent stimulation of CFTR by cAMP-dependent protein kinase A.
187 represent subtle changes in the structure of CFTR that are regulated by intracellular pH, in part, at
188 Intrinsic tryptophan fluorescence studies of CFTR showed that phosphorylation reduced iodide-mediated
189 tential utility of (R)-BPO-27 for therapy of CFTR-mediated secretory diarrheas.
190 Our results support the potential utility of CFTR-targeted activators as a novel prosecretory treatme
191 nteraction profile, but has little effect on CFTR expression.
192                 Consistent with an effect on CFTR gating behavior, we found that altering gating kine
193 gest that they have counteracting effects on CFTR stability.
194 bed indirect effects of calcium signaling on CFTR or other calcium-activated chloride channels; here,
195 results highlight the importance of not only CFTR but also BK channel function in maintaining ASL hom
196                  In addition, overexpressing CFTR might produce a greater benefit than expressing CFT
197 and apical Cl(-) and HCO3(-) permeabilities (CFTR), and reducing the activity of the basolateral Cl(-
198                             Na2S potentiated CFTR stimulation by forskolin, but not that by IBMX.
199 ss entire CFTR populations, we used purified CFTR proteins and macroscopic CFTR Cl(-) currents.
200  the single-channel conductance (g) in R117H-CFTR, but found a approximately 13-fold lower open proba
201 rate that a synergistic improvement of R117H-CFTR function can be accomplished with a combined regime
202 acterizations of the gating defects of R117H-CFTR led to the conclusion that the mutation decreases P
203 pletely rectifies the gating defect of R117H-CFTR.
204 se reagents potentiate synergistically R117H-CFTR gating to a level that allows accurate assessments
205 ) domain, which was sufficient in regulating CFTR biogenesis.
206 ibrosis transmembrane conductance regulator (CFTR or ABCC7; i.e., G551D, S1251N, and G1349D), that we
207 ibrosis transmembrane conductance regulator (CFTR) activator with an EC50 of approximately 200 nM and
208 ibrosis transmembrane conductance regulator (CFTR) activity and lung function in people with cystic f
209 ibrosis transmembrane conductance regulator (CFTR) and dystrophin (DMD).
210 ibrosis transmembrane conductance regulator (CFTR) and large-conductance, Ca(2+)-activated, and volta
211 ibrosis transmembrane conductance regulator (CFTR) anion channel causes misfolding and premature degr
212 ibrosis transmembrane conductance regulator (CFTR) anion channels and solute carrier family 26 member
213 ibrosis transmembrane conductance regulator (CFTR) channel, which can result in chronic lung disease.
214 ibrosis transmembrane conductance regulator (CFTR) chloride channel occurs in these diarrheas.
215 ibrosis transmembrane conductance regulator (CFTR) chloride channel, leading to defective apical chlo
216 ibrosis transmembrane conductance regulator (CFTR) Cl(-) channel.
217 ibrosis transmembrane conductance regulator (CFTR) combined with hyperactivation of the epithelial so
218 ibrosis transmembrane conductance regulator (CFTR) first cytosolic loop (CL1) and nucleotide binding
219 ibrosis transmembrane conductance regulator (CFTR) folding defect responsible for >90% of CF cases.
220 ibrosis Transmembrane Conductance Regulator (CFTR) gene affect CFTR protein biogenesis or its functio
221 ibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF), but are not good
222 ibrosis transmembrane conductance regulator (CFTR) gene, is capable of correcting CFTR-dependent chlo
223 ibrosis transmembrane conductance regulator (CFTR) has lagged behind research into the NBD1 domain, i
224 ibrosis transmembrane conductance regulator (CFTR) have been described that confer a range of molecul
225 ibrosis transmembrane conductance regulator (CFTR) have blunted induction of PI3K/AKT signaling in re
226 ibrosis transmembrane conductance regulator (CFTR) in placebo-controlled studies and patients aged 6-
227  the CF transmembrane conductance regulator (CFTR) interacted directly and this interaction was neces
228 ibrosis transmembrane conductance regulator (CFTR) is a multidomain membrane protein that functions a
229 ibrosis transmembrane conductance regulator (CFTR) is an anion channel evolved from an ATP-binding ca
230 ibrosis transmembrane conductance regulator (CFTR) is an ATP-binding cassette (ABC) transporter that
231 ibrosis transmembrane conductance regulator (CFTR) is an ATP-gated Cl(-) channel defective in the gen
232 ibrosis transmembrane conductance regulator (CFTR) is an epithelial anion channel and a key regulator
233 ibrosis transmembrane conductance regulator (CFTR) is key for the optimization of therapeutics as wel
234 ibrosis transmembrane conductance regulator (CFTR) is the most common CF causing mutation.
235 ibrosis Transmembrane Conductance Regulator (CFTR) is the secretory chloride/bicarbonate channel in a
236 ibrosis transmembrane conductance regulator (CFTR) modulators tezacaftor (VX-661) and ivacaftor (VX-7
237 ibrosis transmembrane conductance regulator (CFTR) mutation in humans, DeltaF508, show increased morb
238 ibrosis transmembrane conductance regulator (CFTR) protein levels, and transepithelial resistance.
239 is (CF) transmembrane conductance regulator (CFTR) regulates bile secretion and other functions at th
240 ibrosis transmembrane conductance regulator (CFTR) that compromise its chloride channel activity.
241 ibrosis transmembrane conductance regulator (CFTR) that reduces Pseudomonas aeruginosa culture positi
242 ibrosis transmembrane conductance regulator (CFTR) W1282X PTC (a UGA codon) in the context of its thr
243 ibrosis transmembrane conductance regulator (CFTR), a 25% reduction of the single-channel conductance
244 ibrosis transmembrane conductance regulator (CFTR), F508del, is initiated by binding of the small hea
245 ibrosis transmembrane conductance regulator (CFTR), leading to detrimental changes to protein stabili
246 ibrosis transmembrane conductance regulator (CFTR), which is defective in the genetic disease cystic
247 g in CF transmembrane conductance regulator (CFTR)-deficient organoids and by nasal potential differe
248 ibrosis transmembrane conductance regulator (CFTR).
249 ibrosis transmembrane conductance regulator (CFTR).
250 mon cystic fibrosis transmembrane regulator (CFTR) mutation that causes cystic fibrosis.
251 TR in CF and the action of drugs that repair CFTR gating defects.
252 and a CFTR mutation associated with residual CFTR function.
253                                      Several CFTR homology models have been developed using bacterial
254  of a 2.8 Mb chromosome 7 region surrounding CFTR in a panel of cell types.
255                We tested the hypothesis that CFTR is expressed in airway smooth muscle and directly a
256 oke-induced channel dysfunction reveals that CFTR activity is downregulated via Smad3 signalling wher
257 evented actin rearrangement, suggesting that CFTR insertion in the plasma membrane results in local r
258 of CFTR in the enteric ganglia suggests that CFTR may play a role in the physiology of the innervatio
259                                          The CFTR-selective inhibitor, CFTRinh-172, modestly reduced
260        The effect of Na2S was blocked by the CFTR inhibitor CFTR_inh172, the adenylyl cyclase inhibit
261 n activity of the mutants was rescued by the CFTR potentiator, ivacaftor (VX-770).
262  cystic fibrosis and were homozygous for the CFTR Phe508del mutation.
263  cystic fibrosis and were homozygous for the CFTR Phe508del mutation.
264 e cystic fibrosis (CF) gene, encodes for the CFTR protein that plays an essential role in anion regul
265 ystic fibrosis is caused by mutations in the CFTR chloride channel, leading to reduced airway surface
266 recessive disease caused by mutations in the CFTR gene that lead to progressive respiratory decline.
267  mitral valve prolapse, and mutations in the CFTR gene.
268                     Two small molecules, the CFTR corrector lumacaftor and the potentiator ivacaftor,
269            Ivacaftor is a potentiator of the CFTR chloride channel and is in worldwide clinical use f
270 d following G418-mediated suppression of the CFTR G542X UGA mutation.
271 ns show residual function and respond to the CFTR potentiator ivacaftor in vitro, whereas ivacaftor a
272  the mutation K1250A or pretreating with the CFTR potentiator VX-770 (Ivacaftor) imparted resistance
273 us of A2BR with that of beta2AR removed this CFTR-dependency.
274 tics stimulates lung fluid secretion through CFTR, an effect which in humans, but not mice, was also
275 y PKA and the minor contribution (</=10%) to CFTR-ATPase activity.
276 CFTR-ATPase activity is inversely related to CFTR anion flux.
277  in patients only, but apparently related to CFTR-contributed NPD level inversely.
278 es but these have low sequence similarity to CFTR and are not ion channels.
279 The major contribution (>/=90%) to the total CFTR-related ATP hydrolysis rate is due to phosphorylati
280 t rAAV-mediated gene transfer of a truncated CFTR functionally rescues the CF phenotype across the na
281 TR1281 channel activity to that of wild type CFTR.
282 al effects of this competition for wild-type CFTR and the major F508del mutant, hinting at potential
283 onfirmed that purified full-length wild-type CFTR is folded and structurally responsive to phosphoryl
284             Compared with purified wild-type CFTR, the full-length F508del-CFTR was about 10 degrees
285 nction of F508del-CFTR, but not of wild-type CFTR.
286  the open-time constant (tauo ) of wild-type CFTR.
287 P analogues in a similar manner as wild-type CFTR.
288                      Among 1,423 unannotated CFTR disease-associated variants, the method identified
289 ents with CF independent of their underlying CFTR mutation.
290 s reinforces its relevance for understanding CFTR function.
291              We also found that some variant CFTR proteins generated by PTC suppression exhibit reduc
292 nt data are consistent with a model in which CFTR is in a closed conformation with two ATPs bound.
293 ction, but it is unknown the degree to which CFTR mutations account for sweat chloride variation.
294                                       Whilst CFTR's function as an ion channel has been well describe
295  Across the tested CF population as a whole, CFTR gene mutations were found to be the primary determi
296 est that PTC suppression in combination with CFTR modulators may be beneficial for the treatment of C
297 ansporters, is cracked open, consistent with CFTR's unique channel function.
298 conformational dynamics and allostery within CFTR.
299  Here, we present the structure of zebrafish CFTR in the phosphorylated, ATP-bound conformation, dete
300 ce of this human CFTR structure to zebrafish CFTR under identical conditions reinforces its relevance

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top